Provided by Tiger Trade Technology Pte. Ltd.

Pfizer

27.96
-0.0600-0.21%
Pre-market: 27.89-0.0700-0.25%07:31 EDT
Volume:27.18M
Turnover:758.93M
Market Cap:158.97B
PE:36.80
High:28.02
Open:28.00
Low:27.77
Close:28.02
52wk High:28.75
52wk Low:23.58
Shares:5.69B
Float Shares:5.64B
Volume Ratio:0.85
T/O Rate:0.48%
Dividend:1.72
Dividend Rate:6.15%
EPS(TTM):0.7599
EPS(LYR):1.36
ROE:5.01%
ROA:5.78%
PB:1.87
PE(LYR):20.49

Loading ...

Pfizer - Litfulo Safety Profile in Nsv Consistent with Prior Data; no New Safety Signals

THOMSON REUTERS
·
Jul 30

Pfizer Announces Positive Topline Phase 3 Results for Litfulo in Patients with Nonsegmental Vitiligo

THOMSON REUTERS
·
Jul 30

Pfizer - Litfulo Phase 3 Studies Meet Co-Primary Endpoints at Week 52 in Vitiligo

THOMSON REUTERS
·
Jul 30

New York City has paused construction at several office-to-apartment conversions since Pfizer tower structural problems

CNN Business
·
Jul 30

NYC Officials Halt Construction at Third Manhattan Conversion Project

Dow Jones
·
Jul 30

BioNTech and Pfizer Secure EU Approval for XFG-Adapted COVID-19 Vaccine for 2026-2027 Season

TIPRANKS
·
Jul 30

Pfizer, BioNTech Updated Covid Vaccine Gets Europe Approval

Dow Jones
·
Jul 30

EU Authorizes Pfizer-BioNTech XFG-adapted COVID Vaccine for Ages 6 Months and Up

Reuters
·
Jul 30

Pfizer - Shipping of Xfg-Adapted Covid-19 Vaccine to Begin Soon

THOMSON REUTERS
·
Jul 30

Earning Preview: Pfizer this quarter’s revenue is expected to increase by 6.35%, and institutional views are cautious

Earnings Agent
·
Jul 29

Pfizer Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jul 29

Movement Alert|Pfizer Rises 3.08% in Regular Trading, Pharma Sector Broadly Lifted by GlaxoSmithKline Strong Q2 Earnings

Market Focus
·
Jul 28

Pfizer: Hold Rating Reiterated as Analyst Keeps $28 Price Target Unchanged Amid Balanced Pipeline Prospects and LOE Headwinds

TIPRANKS
·
Jul 28

Pfizer Ltd June-Quarter Net Profit 2.04 Billion Rupees

Reuters
·
Jul 28

Pfizer’s Bold Pipeline Bets Aim to Revive PFE

TIPRANKS
·
Jul 25

Pfizer’s PF-08057418 Clears Phase 1 Safety Milestone, Offering a Quiet Boost to Pipeline Confidence

TIPRANKS
·
Jul 25

How Investors May Respond To Pfizer (PFE) Prostate Cancer Combo Drug Label Expansion Push

Simply Wall St.
·
Jul 24

Analysts Offer Insights on Healthcare Companies: Pfizer (PFE) and Healthcare Services (HCSG)

TIPRANKS
·
Jul 23

NYSE Most Active Issues

Dow Jones
·
Jul 23

Pfizer's Talzenna-xtandi Combo Gets FDA Priority Review for Earlier-stage Prostate Cancer

Dow Jones
·
Jul 23